Luminai Raises $38M and Partners with Cleveland Clinic

Key Takeaways

• Luminai raised $38M Series B led by Peak XV Partners
• Partnership automates 80% of Cleveland Clinic’s referral documents
• AI tackles unstructured data in healthcare admin workflows
• Founder Kesava, former Rubik’s Cube record holder, leads company

Pulse Analysis

Healthcare administrators have long wrestled with fragmented, paper‑heavy processes that drain resources and slow patient access. The market for AI‑driven workflow automation is projected to exceed $10 billion by 2030, driven by the need to digitize referrals, billing, and scheduling across sprawling networks. Luminai’s solution targets the core bottleneck—unstructured data—by using large‑language models and computer‑vision to extract, classify, and route clinical information in real time, a capability that few vendors have successfully deployed at scale.

The partnership with Cleveland Clinic, a 80,000‑employee system spanning 23 hospitals, serves as a high‑visibility proof point. Luminai’s agents now ingest thousands of daily referrals, many still arriving via fax, and achieve more than 80% automation on document types that previously required full human review. This translates into measurable reductions in staff workload, faster patient onboarding, and lower operational overhead. Cleveland Clinic’s Chief Digital Officer highlighted the strategic goal of shifting caregiver time from administrative chores to direct patient interaction, underscoring the tangible clinical benefits of AI integration.

For investors, Luminai’s trajectory illustrates the upside of backing under‑represented founders who combine technical acumen with relentless problem‑solving. Unshackled Ventures’ early visa support and seed capital enabled Kesava to scale from a co‑working space to a multi‑stage funded startup. As AI adoption accelerates, similar collaborations between health systems and immigrant‑led tech firms are likely to proliferate, reshaping the competitive landscape and delivering both financial returns and societal impact.